20096109

Source:http://linkedlifedata.com/resource/pubmed/id/20096109

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0017337, umls-concept:C0021747, umls-concept:C0087111, umls-concept:C0205210, umls-concept:C0332281, umls-concept:C0441655, umls-concept:C0666743, umls-concept:C0851285, umls-concept:C0871261, umls-concept:C1415900, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	1
pubmed:dateCreated	2010-5-18
pubmed:abstractText	Cross-regulation between TNF and type I IFN has been postulated to play an important role in autoimmune diseases. Therefore, we determined the effect of TNF blockade in rheumatoid arthritis (RA) on the type I IFN response gene activity in relation to clinical response.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-11083258, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-11244034, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-12604793, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-12642603, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-12700592, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-15077311, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-15142523, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-15511676, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-15657875, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-15728381, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-15868633, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-15880830, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-16273792, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-16837931, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-17182626, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-17223656, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-17515957, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-17599733, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-17804842, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-17983157, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-18050196, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-18155297, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-18345002, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-18438842, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-18579578, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-18625621, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-18991285, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-19933783, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-2058872, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-7716713, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-7934491, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-8546736, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-9321530, http://linkedlifedata.com/resource/pubmed/commentcorrection/20096109-9778226
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101154438
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon Type I, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status	MEDLINE
pubmed:issn	1478-6362
pubmed:author	pubmed-author:BaetenDominique LDL, pubmed-author:CantaertTinekeT, pubmed-author:DijkmansBen AcBA, pubmed-author:ParrotPP, pubmed-author:RustenburgFrançoisF, pubmed-author:VerweijCornelis LCL, pubmed-author:WijbrandtsCarla ACA, pubmed-author:van BaarsenLisa GmLG, pubmed-author:van der Pouw KraanTineke CtmTC
pubmed:issnType	Electronic
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	R11
pubmed:dateRevised	2010-9-28
pubmed:meshHeading	pubmed-meshheading:20096109-Adult, pubmed-meshheading:20096109-Aged, pubmed-meshheading:20096109-Antibodies, Monoclonal, pubmed-meshheading:20096109-Antirheumatic Agents, pubmed-meshheading:20096109-Arthritis, Rheumatoid, pubmed-meshheading:20096109-Female, pubmed-meshheading:20096109-Gene Expression, pubmed-meshheading:20096109-Gene Expression Profiling, pubmed-meshheading:20096109-Humans, pubmed-meshheading:20096109-Interferon Type I, pubmed-meshheading:20096109-Male, pubmed-meshheading:20096109-Middle Aged, pubmed-meshheading:20096109-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:20096109-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:20096109-Treatment Outcome, pubmed-meshheading:20096109-Tumor Necrosis Factor-alpha
pubmed:year	2010
pubmed:articleTitle	Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment.
pubmed:affiliation	Department of Pathology, VU University Medical Center, De Boelelaan 1118, 1081 HZ, Amsterdam, The Netherlands. e.g.vanbaarsen@amc.uva.nl
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't